小分子药物提供与生物药物相比较的健康益处,成本更低
Katherine A Clifford1, A Alex Levine2, Daniel E Enright3
1Katherine A. Clifford, Tufts Medical Center, Boston, Massachusetts.
Health affairs (Project Hope)
|November 4, 2024
概括
小分子药物和生物制剂提供类似的健康益处,但小分子药物更具成本效益. 这项研究表明,医疗保险价格谈判时间表应该对两种药物类型相同.
科学领域:
- 卫生经济学 卫生经济学
- 药物经济学 药物经济学
- 药物政策 药物政策
背景情况:
- "2022年通货膨胀减缓法案"规定,小分子药物 (FDA批准后9年) 和生物制品 (13年) 的医疗保险谈判时间表不同.
- 这种政策造成了价格谈判时间的差异,促使对这些药物类别的相对价值和成本效益进行评估.
研究的目的:
- 为了比较小分子药物和生物制剂的增量质量调整寿命年 (QALY) 收益,成本和成本效益比率 (ICER).
- 为制定有关不同类型药物的医疗保险价格谈判时间表的政策决策提供信息.
主要方法:
- 从1999-2018年对FDA批准的小分子药物和生物制剂的分析.
- 增量QALY收益,增量成本和ICERs的比较.
- 使用曼-惠特尼U和科尔摩戈罗夫-斯米尔诺夫测试进行统计分析.
主要成果:
- 这两种药物类型都产生了可比的增量QALY增益 (0.08对于小分子而不是0.10对于生物药物).
- 小分子药物表现出明显较低的增量成本 (4,738美元与16,020美元) 和更有利的ICER (108,314美元/QALY与228,286美元/QALY).
结论:
- 小分子药物和生物制剂在QALY增益方面提供了相似的治疗价值.
- 这些发现支持重新考虑差异化的医疗保险价格谈判时间表,以实现平价,因为小分子药物的成本效益更高.
更多相关视频
06:26Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
Published on: January 24, 2025
938
07:25In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
17.7K
相关概念视频
Bioequivalence: Overview
926
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
926
Biopharmaceutics and Pharmacokinetics: Overview
1.9K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
1.9K
Pharmacokinetic Models: Comparison and Selection Criterion
46
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
46
Prodrugs
2.5K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.5K
Factors Affecting Drug Response: Overview
1.9K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.9K
Principles of Drug Action
5.9K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
5.9K
